TDR Targets

Basic information

Technical information

Name: Unnamed compound
MW: 289.368 | Formula: C16H16FNOS
H donors: 0 H acceptors: 1 LogP: 2.84 Rotable bonds: 3
Rule of 5 violations (Lipinski): 1
SMILES: O=C1C[C@@H]([C@@H](N1C)C(c1cccs1)F)c1ccccc1
InChi: 1S/C16H16FNOS/c1-18-14(19)10-12(11-6-3-2-4-7-11)16(18)15(17)13-8-5-9-20-13/h2-9,12,15-16H,10H2,1H3/t12-,15?,16-/m1/s1
InChiKey: ZVQBWIOXNUGUTL-IATLWXBXSA-N

Network

Hover on a compound node to display the structore

Target Layer

Model Organisms

Species	Viewmode
Arabidopsis thaliana
Caenorhabditis elegans
Dictyostelium discoideum
Drosophila melanogaster
Escherichia coli
Homo sapiens
Mus musculus
Oryza sativa
Saccharomyces cerevisiae
Schmidtea mediterranea
Other organisms

TDR Pathogens:

Species	Viewmode
Brugia malayi
Chlamydia trachomatis
Echinococcus granulosus
Entamoeba histolytica
Echinococcus multilocularis
Giardia lamblia
Leishmania major
Loa Loa (eye worm)
Mycobacterium leprae
Mycobacterium tuberculosis
Mycobacterium ulcerans
Onchocerca volvulus
Plasmodium falciparum
Plasmodium vivax
Schistosoma mansoni
Trypanosoma brucei
Trypanosoma cruzi
Toxoplasma gondii
Treponema pallidum
Trichomonas vaginalis
Wolbachia endosymbiont of Brugia malayi

Other Pathogens:

Species	Viewmode
Babesia bovis
Candida albicans
Cryptosporidium hominis
Cryptosporidium parvum
Leishmania braziliensis
Leishmania donovani
Leishmania infantum
Leishmania mexicana
Neospora caninum
Plasmodium berghei
Plasmodium knowlesi
Plasmodium yoelii
Schistosoma japonicum
Trypanosoma brucei gambiense
Trypanosoma congolense
Theileria parva

Compound Layer

This is a work in progress. Come back soon to try this features!

Clustering layers

This is a work in progress. Come back soon to try this features!

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species	Target name	Source	Bibliographic reference
Homo sapiens	hydroxysteroid (17-beta) dehydrogenase 2	Starlite/ChEMBL	References

Predicted pathogen targets for this compound

By orthology

No druggable targets predicted by orthology data

By sequence similarity to non orthologous known druggable targets

Species	Potential target	Known druggable target	Length	Alignment span	Identity
Echinococcus multilocularis	Dehydrogenase:reductase SDR family	hydroxysteroid (17-beta) dehydrogenase 2	387 aa	359 aa	24.8 %

Ranking Plot

Putative Targets List

Species	Potential target	Raw	Global	Species
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	NAD(P)H dehydrogenase, putative	0.0162	1	1
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Echinococcus multilocularis	Peptidase C19, ubiquitin carboxyl terminal hydrolase 2	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	FMN-dependent NADH-azoreductase, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	NAD(P)H dehydrogenase, putative	0.0162	1	1
Trypanosoma cruzi	ubiquitin carboxyl-terminal hydrolase, putative	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	NAD(P)H dehydrogenase, putative	0.0162	1	1
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0121	0.6776	0.6776
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Brugia malayi	Ubiquitin carboxyl-terminal hydrolase family protein	0.0036	0	0.5
Trichomonas vaginalis	NAD(P)H dehydrogenase, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	NAD(P)H dehydrogenase, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Schistosoma mansoni	ubiquitin-specific peptidase 8 (C19 family)	0.0036	0	0.5
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Entamoeba histolytica	iron-sulfur flavoprotein, putative	0.004	0.0319	1
Echinococcus multilocularis	ubiquitin carboxyl terminal hydrolase 8	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Giardia lamblia	NADPH oxidoreductase, putative	0.0162	1	1
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Echinococcus granulosus	ubiquitin specific protease 41	0.0036	0	0.5
Giardia lamblia	NADPH oxidoreductase, putative	0.0162	1	1
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Echinococcus granulosus	Peptidase C19 ubiquitin carboxyl terminal hydrolase 2	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trypanosoma brucei	ubiquitin carboxyl-terminal hydrolase, putative	0.0036	0	0.5
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Loa Loa (eye worm)	hypothetical protein	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Schistosoma mansoni	ubiquitin-specific peptidase 2 (C19 family)	0.0036	0	0.5
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Echinococcus multilocularis	ubiquitin specific protease 41	0.0036	0	0.5
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trypanosoma cruzi	ubiquitin carboxyl-terminal hydrolase, putative	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Leishmania major	ubiquitin hydrolase, putative,cysteine peptidase, Clan CA, family C19, putative	0.0036	0	0.5
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.0162	1	1
Entamoeba histolytica	modulator of drug activity B homolog, putative	0.004	0.0319	1
Echinococcus granulosus	ubiquitin carboxyl terminal hydrolase 8	0.0036	0	0.5
Entamoeba histolytica	hypothetical protein	0.004	0.0319	1
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	modulator of drug activity B, putative	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319
Trichomonas vaginalis	conserved hypothetical protein	0.004	0.0319	0.0319

Activities

Activity type	Activity value	Assay description	Source	Reference
IC50 (binding)	= 2.98 uM	Inhibitory concentration against 17 beta hydroxysteroid dehydrogenase type 2 (type II 17-beta-HSD II)	ChEMBL.	15890515
IC50 (binding)	= 2.98 uM	Inhibitory concentration against 17 beta hydroxysteroid dehydrogenase type 2 (type II 17-beta-HSD II)	ChEMBL.	15890515

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.

Detailed information for compound 330755